Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results
- PMID: 37928360
- PMCID: PMC10624135
- DOI: 10.5334/gh.1272
Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results
Abstract
Background: Socioeconomic factors contribute to a more severe impact of COVID-19 in Latin American and Caribbean (LA&C) countries than in developed countries. Patients with a severe or critical illness can develop respiratory and cardiovascular complications.
Objective: To describe a LA&C population with COVID-19 to provide information related to this disease, in-hospital cardiovascular complications, and in-hospital mortality.
Methods: The CARDIO COVID-19-20 Registry is an observational, multicenter, prospective, and hospital-based registry of patients with confirmed COVID-19 infection that required in-hospital treatment in LA&C. Enrollment of patients started on May 01, 2020, and ended on June 30, 2021.
Results: The CARDIO COVID-19-20 Registry included 3260 patients from 44 institutions of 14 LA&C countries. 63.2% patients were male and median age was 61.0 years old. Most common comorbidities were overweight/obesity (49.7%), hypertension (49.0%), and diabetes mellitus (26.7%). Most frequent cardiovascular complications during hospitalization or reported at discharge were cardiac arrhythmia (9.1%), decompensated heart failure (8.5%), and pulmonary embolism (3.9%). The number of patients admitted to the Intensive Care Unit (ICU) was 1745 (53.5%), and median length of their stay at the ICU was 10.0 days. Support required in ICU included invasive mechanical ventilation (34.2%), vasopressors (27.6%), inotropics (10.3%), and vasodilators (3.7%). Rehospitalization after 30-day post discharge was 7.3%. In-hospital mortality and 30-day post discharge were 25.5% and 2.6%, respectively.
Conclusions: According to our findings, more than half of the LA&C population with COVID-19 assessed required management in ICU, with higher requirement of invasive mechanical ventilation and vasoactive support, resulting in a high in-hospital mortality and a considerable high 30-day post discharge rehospitalization and mortality.
Keywords: COVID-19; Caribbean; Coronavirus; Heart Failure; Latin America; SARS-CoV-2.
Copyright: © 2023 The Author(s).
Conflict of interest statement
The authors have no competing interests to declare.
Figures
Similar articles
-
Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry.Glob Heart. 2021 Feb 12;16(1):14. doi: 10.5334/gh.925. Glob Heart. 2021. PMID: 33833938 Free PMC article.
-
Biochemical differences based on sex and clusters of biomarkers in patients with COVID-19: analysis from the CARDIO COVID 19-20 registry.BMC Cardiovasc Disord. 2025 Mar 5;25(1):147. doi: 10.1186/s12872-025-04565-3. BMC Cardiovasc Disord. 2025. PMID: 40045210 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review.Clin Microbiol Infect. 2021 Jan;27(1):47-54. doi: 10.1016/j.cmi.2020.10.017. Epub 2020 Oct 23. Clin Microbiol Infect. 2021. PMID: 33190794 Free PMC article.
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. Updated.
Cited by
-
Association of Abnormal Cardiac Biomarkers and Cardiovascular Complications, with Mortality in Patients with SARS-CoV-2 Infection in Latin America.J Cardiovasc Dev Dis. 2024 Jun 30;11(7):205. doi: 10.3390/jcdd11070205. J Cardiovasc Dev Dis. 2024. PMID: 39057625 Free PMC article.
-
Pre-Existing Atrial Fibrillation in Hospitalized Patients with COVID-19: Insights from the CARDIO COVID 19-20 Registry.J Cardiovasc Dev Dis. 2024 Jul 4;11(7):210. doi: 10.3390/jcdd11070210. J Cardiovasc Dev Dis. 2024. PMID: 39057630 Free PMC article.
-
Marked Global Differences in Mortality in Male Patients with COVID-19: An Analysis of the CARDIO COVID 19-20 and WHF COVID-19 CVD Studies.Glob Heart. 2025 Feb 28;20(1):21. doi: 10.5334/gh.1403. eCollection 2025. Glob Heart. 2025. PMID: 40026348 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous